Empirico
Darren Wakefield has extensive experience in chemistry and analytics, holding director positions at Empirico Inc., NanoSUR, and Arrowhead Pharmaceuticals, Inc. Darren has managed and led teams in various disciplines such as polymer chemistry, delivery strategies, and oligonucleotide synthesis. Darren has made significant contributions in making RNA triggers more nuclease resistant and optimizing new delivery platforms, resulting in improvements in potency and efficacy. Darren's expertise also includes development of polymer delivery platforms, small molecule PK modulators, conjugation chemistries, and targeting modalities. Darren holds a Bachelor of Applied Science in Chemistry from University of Minnesota Duluth and Southwest Minnesota State University.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.